New gut drug may help treat long COVID
A groundbreaking study conducted at the Chinese University of Hong Kong has brought new hope for patients suffering from long COVID, also known as...
Is it COVID, flu, or allergies? How to protect yourself and loved ones this...
Flu season is here once again.
And many questions have formed over the last couple of years about how you can stay safe from both...
Probiotics can be a simple aid against COVID
In recent times, a group of scientists found out that a specific type of good bacteria, known as lactobacillus, can help delay and lessen...
COVID-19 variant JN.1 is on the rise. Here’s what you need to know
A new COVID-19 variant is now estimated to make up about 20% of COVID-19 cases in the United States.
The World Health Organization (WHO) recently...
I have COVID. How likely am I to get long COVID?
EG.5 or the Eris COVID variant is dominant in parts of Australia. Eris, along with other circulating strains, are descendants of Omicron.
While these strains...
Scientists find long-term brain injury markers in people with COVID-19
A new study, recently published in Nature, uncovers significant findings about brain injury markers in COVID-19 patients.
This research is a major output from the...
New COVID-19 vaccine shows strong response against omicron variants
Researchers from Karolinska Institutet and Danderyd Hospital have revealed promising results from their latest study on the updated COVID-19 vaccine's efficacy against various SARS-CoV-2...
Scientists find promising new drug for mild COVID-19 symptoms
In a recent clinical trial called SIGMA4COVID, researchers from Catalonia and Galicia have discovered a potential new treatment for people with mild COVID-19 symptoms....
Probiotics can reduce COVID symptoms and delay disease, study finds
In a new study, a group of researchers from Duke Health examined whether probiotics, specifically a type called lactobacillus, help fight against COVID-19.
They decided...
Keeping an eye on JN.1: The new COVID variant of interest
The World Health Organization (WHO) recently designated a new COVID-19 variant, JN.1, as a "variant of interest."
This classification means that health officials worldwide are...